The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Complex cytogenetics in myeloid malignancies: redefining complex karyotypes
Alex Bataller, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares insights into a retrospective analysis exploring complex karyotypes in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). This analysis aims to identify trends and vulnerabilities to better inform treatment design. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
